| Sign In to gain access to subscriptions and/or personal tools. |
A double-blind placebo-controlled study of rolipram in depressed in-patientsMedical College of St Bartholomews Hospital
Medical College of St Bartholomews Hospital
The London Hospital In a double-blind study, rolipram, a new phosphodiesterase inhibitor, was com pared to placebo in 20 hospitalized depressed patients. There was a high rate of non- completion (11 out of 20) at 28 days. No difference was found in the clinical improvement between the two groups.
Journal of Psychopharmacology, Vol. 3, No. 3,
169-174 (1989) |
|||